$IDXX Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in IDEXX LABORATORIES INC /DE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in IDEXX LABORATORIES INC /DE. Get notifications about new insider transactions in IDEXX LABORATORIES INC /DE for free.
Page: < prev 1 2 3 4 5 6 7 8 ... 28 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 295.21 | 500 | 147,604 | 810,361 | 810.9 K to 810.4 K (-0.06 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 294.84 | 7,827 | 2,307,728 | 818,188 | 826 K to 818.2 K (-0.95 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 293.78 | 6,846 | 2,011,197 | 825,034 | 831.9 K to 825 K (-0.82 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 292.71 | 1,406 | 411,543 | 826,440 | 827.8 K to 826.4 K (-0.17 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 290.16 | 100 | 29,016 | 826,540 | 826.6 K to 826.5 K (-0.01 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 289.48 | 805 | 233,035 | 827,345 | 828.2 K to 827.3 K (-0.10 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 288.43 | 634 | 182,865 | 827,979 | 828.6 K to 828 K (-0.08 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 295.02 | 7,042 | 2,077,502 | 827,979 | 835 K to 828 K (-0.84 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 293.94 | 8,104 | 2,382,070 | 835,021 | 843.1 K to 835 K (-0.96 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 293.04 | 3,000 | 879,120 | 843,125 | 846.1 K to 843.1 K (-0.35 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 291.46 | 100 | 29,146 | 846,125 | 846.2 K to 846.1 K (-0.01 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 290.35 | 100 | 29,035 | 846,225 | 846.3 K to 846.2 K (-0.01 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 289.52 | 900 | 260,564 | 846,325 | 847.2 K to 846.3 K (-0.11 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 288.50 | 758 | 218,682 | 847,225 | 848 K to 847.2 K (-0.09 %) |
| Feb 21 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 288.00 | 1,021 | 294,048 | 847,983 | 849 K to 848 K (-0.12 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | M | 82.00 | 5,902 | 483,964 | 0 | |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Option Exercise | M | 63.95 | 1,666 | 106,541 | 0 | |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Sell | S | 286.89 | 5,902 | 1,693,240 | 3,321 | 9.2 K to 3.3 K (-63.99 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Buy | M | 82.00 | 5,902 | 483,964 | 9,223 | 3.3 K to 9.2 K (+177.72 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Sell | S | 286.89 | 1,666 | 477,963 | 3,321 | 5 K to 3.3 K (-33.41 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Buy | M | 63.95 | 1,666 | 106,541 | 4,987 | 3.3 K to 5 K (+50.17 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Option Exercise | M | 43.68 | 8,790 | 383,947 | 0 | |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 286.98 | 1,200 | 344,378 | 2,916 | 4.1 K to 2.9 K (-29.15 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Sell | S | 286.18 | 7,590 | 2,172,091 | 4,116 | 11.7 K to 4.1 K (-64.84 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 8,790 | 0 | 11,796 | 3 K to 11.8 K (+292.42 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Gift | G | 0.00 | 8,790 | 0 | 584 | 9.4 K to 584 (-93.77 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | SZOSTAK M ANNE | Director | Buy | M | 43.68 | 8,790 | 383,947 | 9,734 | 944 to 9.7 K (+931.14 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 288.98 | 1,100 | 317,878 | 849,004 | 850.1 K to 849 K (-0.13 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 288.17 | 2,779 | 800,828 | 850,104 | 852.9 K to 850.1 K (-0.33 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 287.07 | 19,035 | 5,464,360 | 852,883 | 871.9 K to 852.9 K (-2.18 %) |
| Feb 20 2020 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Sell | S | 286.23 | 17,086 | 4,890,512 | 871,918 | 889 K to 871.9 K (-1.92 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | CVP, Gen. Counsel & ... | Option Exercise | M | 0.00 | 484 | 0 | 2,798 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | CVP, Gen. Counsel & ... | Option Exercise | A | 0.00 | 866 | 0 | 3,282 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | CVP, Gen. Counsel & ... | Option Exercise | A | 288.78 | 8,906 | 2,571,875 | 8,906 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | CVP, Gen. Counsel & ... | Payment of Exercise | F | 288.78 | 153 | 44,183 | 353 | 506 to 353 (-30.24 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Underberg Sharon E. | CVP, Gen. Counsel & ... | Buy | M | 0.00 | 484 | 0 | 506 | 22 to 506 (+2,200.00 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 157 | 0 | 2,632 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 168 | 0 | 2,789 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 212 | 0 | 2,957 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 405 | 0 | 3,169 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 0.00 | 345 | 0 | 3,574 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | A | 0.00 | 736 | 0 | 3,919 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | A | 288.78 | 7,570 | 2,186,065 | 7,570 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Payment of Exercise | F | 288.78 | 388 | 112,047 | 12,869 | 13.3 K to 12.9 K (-2.93 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 157 | 0 | 13,257 | 13.1 K to 13.3 K (+1.20 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 168 | 0 | 13,100 | 12.9 K to 13.1 K (+1.30 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 212 | 0 | 12,932 | 12.7 K to 12.9 K (+1.67 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 405 | 0 | 12,720 | 12.3 K to 12.7 K (+3.29 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 0.00 | 345 | 0 | 12,315 | 12 K to 12.3 K (+2.88 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 182 | 0 | 2,647 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 211 | 0 | 2,829 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 212 | 0 | 3,040 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 221 | 0 | 3,252 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 0.00 | 188 | 0 | 3,474 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | A | 0.00 | 649 | 0 | 3,661 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | A | 288.78 | 6,680 | 1,929,050 | 6,680 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Payment of Exercise | F | 288.78 | 290 | 83,746 | 12,779 | 13.1 K to 12.8 K (-2.22 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 182 | 0 | 13,069 | 12.9 K to 13.1 K (+1.41 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 211 | 0 | 12,887 | 12.7 K to 12.9 K (+1.66 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 212 | 0 | 12,676 | 12.5 K to 12.7 K (+1.70 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 221 | 0 | 12,464 | 12.2 K to 12.5 K (+1.81 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Buy | M | 0.00 | 188 | 0 | 12,243 | 12.1 K to 12.2 K (+1.56 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 127 | 0 | 2,294 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 126 | 0 | 2,421 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 150 | 0 | 2,547 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 243 | 0 | 2,697 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | M | 0.00 | 207 | 0 | 2,940 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 0.00 | 866 | 0 | 3,147 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Option Exercise | A | 288.78 | 8,906 | 2,571,875 | 8,906 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Payment of Exercise | F | 288.78 | 259 | 74,794 | 16,493 | 16.8 K to 16.5 K (-1.55 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 127 | 0 | 16,752 | 16.6 K to 16.8 K (+0.76 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 126 | 0 | 16,625 | 16.5 K to 16.6 K (+0.76 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 150 | 0 | 16,499 | 16.3 K to 16.5 K (+0.92 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 243 | 0 | 16,349 | 16.1 K to 16.3 K (+1.51 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | POLEWACZYK JAMES F | Executive Vice Pres ... | Buy | M | 0.00 | 207 | 0 | 16,106 | 15.9 K to 16.1 K (+1.30 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 435 | 0 | 7,674 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 505 | 0 | 8,109 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 459 | 0 | 8,614 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 810 | 0 | 9,073 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | M | 0.00 | 628 | 0 | 9,883 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 0.00 | 1,731 | 0 | 10,511 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Option Exercise | A | 288.78 | 17,813 | 5,144,038 | 17,813 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Payment of Exercise | F | 288.78 | 979 | 282,716 | 49,457 | 50.4 K to 49.5 K (-1.94 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 435 | 0 | 50,436 | 50 K to 50.4 K (+0.87 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 505 | 0 | 50,001 | 49.5 K to 50 K (+1.02 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 459 | 0 | 49,496 | 49 K to 49.5 K (+0.94 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 810 | 0 | 49,037 | 48.2 K to 49 K (+1.68 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MCKEON BRIAN P | Executive VP & CFO | Buy | M | 0.00 | 628 | 0 | 48,227 | 47.6 K to 48.2 K (+1.32 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 435 | 0 | 10,728 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 505 | 0 | 11,163 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 459 | 0 | 11,668 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 737 | 0 | 12,127 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 0.00 | 471 | 0 | 12,864 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | A | 0.00 | 3,896 | 0 | 13,335 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | A | 288.78 | 40,078 | 11,573,725 | 40,078 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Payment of Exercise | F | 288.78 | 1,210 | 349,424 | 44,082 | 45.3 K to 44.1 K (-2.67 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 435 | 0 | 45,292 | 44.9 K to 45.3 K (+0.97 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 505 | 0 | 44,857 | 44.4 K to 44.9 K (+1.14 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 459 | 0 | 44,352 | 43.9 K to 44.4 K (+1.05 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 737 | 0 | 43,893 | 43.2 K to 43.9 K (+1.71 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 0.00 | 471 | 0 | 43,156 | 42.7 K to 43.2 K (+1.10 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 182 | 0 | 2,649 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 197 | 0 | 2,831 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 212 | 0 | 3,028 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 221 | 0 | 3,240 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | M | 0.00 | 188 | 0 | 3,461 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | A | 0.00 | 693 | 0 | 3,649 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Option Exercise | A | 288.78 | 7,125 | 2,057,558 | 7,125 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Payment of Exercise | F | 288.78 | 303 | 87,500 | 2,165 | 2.5 K to 2.2 K (-12.28 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 182 | 0 | 2,468 | 2.3 K to 2.5 K (+7.96 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 197 | 0 | 2,286 | 2.1 K to 2.3 K (+9.43 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 212 | 0 | 2,089 | 1.9 K to 2.1 K (+11.29 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 221 | 0 | 1,877 | 1.7 K to 1.9 K (+13.35 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Lane Michael | Executive Vice Pres ... | Buy | M | 0.00 | 188 | 0 | 1,656 | 1.5 K to 1.7 K (+12.81 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 127 | 0 | 1,953 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 126 | 0 | 2,080 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 88 | 0 | 2,206 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 199 | 0 | 2,294 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | M | 0.00 | 157 | 0 | 2,493 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | A | 0.00 | 693 | 0 | 2,650 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Option Exercise | A | 288.78 | 7,125 | 2,057,558 | 7,125 | |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Payment of Exercise | F | 288.78 | 217 | 62,665 | 10,585 | 10.8 K to 10.6 K (-2.01 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 127 | 0 | 10,802 | 10.7 K to 10.8 K (+1.19 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 126 | 0 | 10,675 | 10.5 K to 10.7 K (+1.19 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 88 | 0 | 10,549 | 10.5 K to 10.5 K (+0.84 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 199 | 0 | 10,461 | 10.3 K to 10.5 K (+1.94 %) |
| Feb 19 2020 | IDXX | IDEXX LABORATORIES ... | Hunt Nimrata | Executive Vice Pres ... | Buy | M | 0.00 | 157 | 0 | 10,262 | 10.1 K to 10.3 K (+1.55 %) |
| Feb 07 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 45.84 | 13,824 | 633,692 | 0 | |
| Feb 07 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Sell | S | 281.97 | 388 | 109,405 | 42,685 | 43.1 K to 42.7 K (-0.90 %) |
| Feb 07 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Sell | S | 280.13 | 100 | 28,013 | 43,073 | 43.2 K to 43.1 K (-0.23 %) |
| Feb 07 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Sell | S | 279.01 | 1,676 | 467,613 | 43,173 | 44.8 K to 43.2 K (-3.74 %) |
| Feb 07 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Sell | S | 277.88 | 3,354 | 931,999 | 44,849 | 48.2 K to 44.8 K (-6.96 %) |
| Feb 07 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Sell | S | 276.71 | 1,337 | 369,958 | 48,203 | 49.5 K to 48.2 K (-2.70 %) |
| Feb 07 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Sell | S | 275.72 | 1,145 | 315,705 | 49,540 | 50.7 K to 49.5 K (-2.26 %) |
| Feb 07 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 45.84 | 13,824 | 633,692 | 50,685 | 36.9 K to 50.7 K (+37.50 %) |
| Feb 03 2020 | IDXX | IDEXX LABORATORIES ... | Vandebroek Sophie V. | Director | Grant | A | 283.73 | 70 | 19,861 | 3,321 | 3.3 K to 3.3 K (+2.15 %) |
| Feb 03 2020 | IDXX | IDEXX LABORATORIES ... | ESSIG STUART | Director | Grant | A | 283.73 | 70 | 19,861 | 862 | 792 to 862 (+8.84 %) |
| Jan 16 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Option Exercise | M | 45.84 | 2,188 | 100,298 | 0 | |
| Jan 16 2020 | IDXX | IDEXX LABORATORIES ... | MAZELSKY JONATHAN JAY | President & CEO | Buy | M | 45.84 | 2,188 | 100,298 | 36,861 | 34.7 K to 36.9 K (+6.31 %) |
| Dec 03 2019 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 251.58 | 277 | 69,688 | 277 | |
| Dec 03 2019 | IDXX | IDEXX LABORATORIES ... | Kingsley Lawrence D | Director | Option Exercise | A | 0.00 | 82 | 0 | 1,229 | |
| Dec 03 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | A | 251.58 | 726 | 182,647 | 726 | |
| Dec 03 2019 | IDXX | IDEXX LABORATORIES ... | AYERS JONATHAN W | Director | Option Exercise | A | 0.00 | 214 | 0 | 214 | |
| Dec 02 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 62.00 | 1,612 | 99,944 | 0 | |
| Dec 02 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Option Exercise | M | 45.84 | 14,750 | 676,140 | 0 | |
| Dec 02 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 62.00 | 1,612 | 99,944 | 11,949 | 10.3 K to 11.9 K (+15.59 %) |
| Dec 02 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 251.31 | 13,306 | 3,343,886 | 10,337 | 23.6 K to 10.3 K (-56.28 %) |
| Dec 02 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Sell | S | 243.16 | 1,444 | 351,121 | 23,643 | 25.1 K to 23.6 K (-5.76 %) |
| Dec 02 2019 | IDXX | IDEXX LABORATORIES ... | TWIGGE GIOVANI | CORPORATE VICE PRES ... | Buy | M | 45.84 | 14,750 | 676,140 | 25,087 | 10.3 K to 25.1 K (+142.69 %) |
| Dec 02 2019 | IDXX | IDEXX LABORATORIES ... | Turner Kathy V | Corporate Vice Pres ... | Option Exercise | M | 64.24 | 7,780 | 499,787 | 0 |